Friday, June 18, 2010 9:58:12 AM
Continued progress twards earnings..hank
Results of Operations and Operating Data
Three Months Ended April 30, 2010 vs. Three Months Ended April 30, 2009
Net revenues for the three months ended April 30, 2010 of $802,885 increased $301,702, or 60 percent, over net revenues of $501,183 reported for the three months ended April 30, 2009. Net revenues are comprised of net billings by AMH under the various fee structures from health plans, medical groups/IPA’s and hospitals, and income from service fee agreements. Increase was attributable to new hospital contracts, increased same-market area growth and expansion of services with existing medical group clients at new hospitals.
Physician practice salaries, benefits and other expenses for the three months ended April 30, 2010 were $674,686, at 84% of net revenues compared to $419,554 for the three months ended April 30, 2009, at 84% of net revenues. Cost of Services includes the payroll and consulting costs of the physicians, all payroll related costs, costs for all medical malpractice insurance and physician privileges. Increase in physician costs were attributable to start-up losses at new hospital contracts and expansions of services at new hospitals in the quarter.
General and administrative expenses include all salaries, benefits, supplies and operating expenses, not specifically related to the day-to-day operations of our physician group practices, including billing and collections functions, and our corporate management and overhead. General and administrative expenses were $85,192, at 11% of net revenues, for the three months ended April 30, 2010. General and Administrative expenses were $172,562 for the three months ended April 30, 2009, at 34% of net revenues. In the first quarter of 2010, the Company recorded non-cash compensation expenses of $30,066, related to the issuance of shares for service, compared to $94,500 of such non-cash costs in the first quarter of 2009. In addition, the Company recorded a favorable write-down of its bad debt reserve of $60,647 compared to $462 increase in bad debt reserve in first quarter of 2009.
Depreciation and amortization expense was $3,006 for the three months ended April 30, 2010, and $10,338 for the comparable three-month period in 2009.
The Company reported a profit from operations of $40,001 for the three months ended April 30, 2010, compared to a loss from operations of $101,272 recorded in the same period of 2009. Net revenues in 2010 continued to benefit from the addition of contracts with hospitals and the hiring of several additional physicians. In addition, the operating profit in 2010 benefitted from the lower non-cash compensation costs.
Interest expense and amortization of financing costs totaled $40,044 for the three months ended April 30, 2010, compared to interest and financing costs of $4,849 in the three months ended April 30, 2009. Interest expense and financing costs in 2010 included interest on the subordinated borrowings of $31,523, and the amortization of financing costs of $9,375, related to these notes. Interest expense in the three months ended April 30, 2009 of $4,849 represents interest expense paid on the SBA loan with Wells Fargo Bank, and interest expense accrued at AMM for the related party notes.
Net Loss was $843 for the three months ended April 30, 2010, compared to a net loss of $106,921 for the three months ended April 30, 2009. The reduction in the net loss was the result of the factors discussed above.
Liquidity and Capital Resources
At April 30, 2010, the Company had cash and cash equivalents of $504,540, compared to cash and cash equivalents of $665,737 at January 31, 2010. The cash balance at April 30, 2010 included $486,216 in a money market brokerage account. There were no short-term borrowings at April 30, 2010 or January 31, 2010. Long-term borrowings totaled $1,247,784 as of April 30, 2010 and $1,247,582 on January 31, 2010.
Net cash used in operating activities totaled $155,830 in the three months ended April 30, 2010, compared to net cash used in operations of $17,464 for the comparable three months ended April 30, 2009. The significantly larger increase in accounts receivable, primarily related to new contracts in the first quarter of 2010, was responsible for the decrease in the operating cash flow.
Net cash used in operating activities for the three months ended April 30, 2010 of $155,830 was comprised of a net loss of $843 for the three month period. Adjustments for non-cash charges which include depreciation, bad debt expense, shares issued for service and amortization of commission cost and debt discount, used $17,997. In addition, net changes in operating assets and liabilities used cash of $136,990
The Company invested $4,568 to develop a Web Site and an $800 advance to an affiliated Company in the first quarter of 2010. We did not spend any cash for investing activities in the comparable three-month period of 2009.
For the three months ended April 30, 2010, the Company did not spend any for financing activities. In the first quarter of 2009, ended April 30, 2009, net cash used in financing activities totaled $7,477 and consisted of principal pay downs on the Company's SBA loan with Wells Fargo Bank.
Recent AMEH News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/24/2024 08:10:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2024 01:25:23 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2024 01:22:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2024 01:07:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2024 10:01:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 10:00:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/19/2024 08:42:53 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/09/2024 04:34:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/04/2024 09:13:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/04/2024 08:47:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 10:03:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:03:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 11:04:01 AM
- Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc. • PR Newswire (US) • 02/22/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 12:30:31 PM
- Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call • PR Newswire (US) • 01/31/2024 01:00:00 PM
- ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership • PR Newswire (US) • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:30:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:30:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 01:30:26 PM
- Apollo Medical Holdings, Inc. Announces Leadership Transitions • PR Newswire (US) • 01/24/2024 01:05:00 PM
- Apollo Medical Holdings, Inc. Announces Planned Corporate Rebrand as Astrana Health • PR Newswire (US) • 01/24/2024 01:00:00 PM
- Apollo Medical Holdings, Inc. Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 01/24/2024 12:00:00 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM